Does IRBESARTAN Cause Condition aggravated? 165 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Condition aggravated have been filed in association with IRBESARTAN (Irbesartan). This represents 1.6% of all adverse event reports for IRBESARTAN.
165
Reports of Condition aggravated with IRBESARTAN
1.6%
of all IRBESARTAN reports
33
Deaths
122
Hospitalizations
How Dangerous Is Condition aggravated From IRBESARTAN?
Of the 165 reports, 33 (20.0%) resulted in death, 122 (73.9%) required hospitalization, and 35 (21.2%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which IRBESARTAN Alternatives Have Lower Condition aggravated Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE